These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29609663)

  • 1. PERSPECTIVE: SOME CONCLUSIONS FROM MY LIFE IN HEALTH TECHNOLOGY ASSESSMENT.
    Banta HD
    Int J Technol Assess Health Care; 2018 Jan; 34(2):131-133. PubMed ID: 29609663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health technology assessment: research trends and future priorities in Europe.
    Nielsen CP; Funch TM; Kristensen FB
    J Health Serv Res Policy; 2011 Jul; 16 Suppl 2():6-15. PubMed ID: 21737525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHALLENGES IN CONTEMPORARY HEALTH TECHNOLOGY ASSESSMENT: A VIEW FROM THE OUTSIDE.
    Oortwijn W; van der Wilt GJ
    Int J Technol Assess Health Care; 2016 Jan; 32(1-2):1-2. PubMed ID: 27064102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of health technology assessment.
    Banta D
    Health Policy; 2003 Feb; 63(2):121-32. PubMed ID: 12543525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Office of Technology Assessment health program.
    Banta D; Behney CJ
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():28-32. PubMed ID: 19519980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies.
    Makady A; Ham RT; de Boer A; Hillege H; Klungel O; Goettsch W;
    Value Health; 2017 Apr; 20(4):520-532. PubMed ID: 28407993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland.
    Allen N; Walker SR; Liberti L; Salek S
    Value Health; 2017 Mar; 20(3):320-328. PubMed ID: 28292476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Netherlands.
    Banta D; Oortwijn WJ
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():143-7. PubMed ID: 19538813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health technology assessment: decentralized and fragmented in the US compared to other countries.
    Perry S; Thamer M
    Health Policy; 1997 Jun; 40(3):177-98. PubMed ID: 10168751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health technology assessment in Denmark: strategy, implementation, and developments.
    Sigmund H; Kristensen FB
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():94-101. PubMed ID: 19505351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HTA Implementation Roadmap in Central and Eastern European Countries.
    Kaló Z; Gheorghe A; Huic M; Csanádi M; Kristensen FB
    Health Econ; 2016 Feb; 25 Suppl 1(Suppl Suppl 1):179-92. PubMed ID: 26763688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical industry's perspective on health technology assessment.
    Lothgren M; Ratcliffe M
    Int J Technol Assess Health Care; 2004; 20(1):97-101. PubMed ID: 15176185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTA and its legal issues: a framework for identifying legal issues in health technology assessment.
    Widrig D; Tag B
    Int J Technol Assess Health Care; 2014 Dec; 30(6):587-94. PubMed ID: 25816824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HEALTH TECHNOLOGY ASSESSMENT IN TURKEY.
    Kahveci R; Koç EM; Küçük EÖ
    Int J Technol Assess Health Care; 2017 Jan; 33(3):402-408. PubMed ID: 28595660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries.
    Oortwijn W; Mathijssen J; Banta D
    Health Policy; 2010 May; 95(2-3):174-84. PubMed ID: 20074829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations?
    ; Neumann PJ; Drummond MF; Jönsson B; Luce BR; Schwartz JS; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2010 Jan; 26(1):71-8. PubMed ID: 20059783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-ordinating health technology assessment in Canada: a European perspective.
    McDaid D
    Health Policy; 2003 Feb; 63(2):205-13. PubMed ID: 12543533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who's afraid of institutionalizing health technology assessment (HTA)?: Interests and policy positions on HTA in the Czech Republic.
    Löblová O
    Health Econ Policy Law; 2018 Apr; 13(2):137-161. PubMed ID: 29108525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health technology assessment in four countries: response from political science.
    Chinitz D
    Int J Technol Assess Health Care; 2004; 20(1):55-60. PubMed ID: 15176177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.